1157 GMT - Danone could have an improvement in its infant-nutrition segment driven by the rise in birth rates in China, Barclays analysts say in a note. Especially given its material presence and significant market-share gains, the analysts add. After eight years of declines, China's National Bureau of Statistics recorded a birth rate increase of around 6% in 2024, they say. China accounts for roughly 40% of Danone's total infant-nutrition sales, the analysts say. Aptamil is the biggest brand across its entire portfolio, with sales of more than 3 billion euros, they say. China accounts for 50% of the global infant-formula market by value, and Danone currently holds a 13% market share, they say. However, it remains uncertain whether the increasing birth rate is a change in the trend or a mostly horoscope-related effect, as 2024 was the Year of the Dragon--a period which is traditionally associated with good fortune in Chinese culture, Barclays says. Shares are up 0.6% at 65.30 euros. (michael.susin@wsj.com)
(END) Dow Jones Newswires
January 20, 2025 06:57 ET (11:57 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.